Prognostic Utility of Platelet-to-Albumin Ratio among Critically Ill Patients with Colorectal Cancer: A Propensity Score Matching Study
Table 2
Summary of results of 28-day mortality and sensitivity analysis.
Original cohort
Matched cohort
Weighted cohort
Validation cohort
HR (95% CI)
value
HR (95% CI)
value
HR (95% CI)
value
HR (95% CI)
value
Unadjusted
2.66 (1.80–3.94)
<0.001
2.20 (1.29–3.73)
0.003
2.51 (1.58–3.99)
<0.001
3.82 (1.99–7.35)
<0.001
Model 1
2.74 (1.85–4.08)
<0.001
2.24 (1.31–3.84)
0.007
2.54 (1.57–4.11)
<0.001
3.77 (1.86–7.64)
<0.001
Model 2
3.07 (2.03–4.64)
<0.001
2.81 (1.59–4.97)
<0.001
2.79 (1.71–4.55)
<0.001
4.59 (2.04–10.34)
<0.001
Model 3
3.44 (2.15–5.49)
<0.001
3.81 (1.98–7.35)
<0.001
3.73 (2.02–6.90)
<0.001
6.79 (2.58–17.87)
<0.001
Model 1 adjusted for age, gender, BMI, ethnicity. Model 2 adjusted for model 1 plus comorbidities and Charlson comorbidity index. Model 3 adjusted for model 2 plus score system, interventions, complications.